[1]
A. Singh, A. A. Khan, and M. S. Khan, “Efficacy of antitubercular drugs in Category 1 tuberculosis patients receiving daily versus intermittent regimen”, Int. J. Heal. Clin. Res., vol. 4, no. 4, pp. 45–47, Feb. 2021.